Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma

Gene

Volumn 569, Issue 1, 2015, Pages 109-117

  Lan, Xiabin ^a   Zhang, Hao ^a   Wang, Zhihong ^a   Dong, Wenwu ^a   Sun, Wei ^a   Shao, Liang ^a   Zhang, Ting ^a   Zhang, Dalin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

LncRNA; Long noncoding RNA; Microarray; MRNA; Papillary thyroid carcinoma

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN P53; TRANSCRIPTOME;

ADULT; ARTICLE; CALCIUM SIGNALING; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FOCAL ADHESION; GENE EXPRESSION; GENE FUNCTION; GENE ONTOLOGY; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PURINE METABOLISM; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THYROID CARCINOMA; THYROID GLAND; UPREGULATION; BIOSYNTHESIS; CARCINOMA; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; PATHOLOGY; THYROID TUMOR;

CARCINOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; TRANSCRIPTOME;

EID: 84937522975     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.05.046     Document Type: Article

References (44)

1. Bartolomei M.S., Zemel S., Tilghman S.M. Parental imprinting of the mouse H19 gene. Nature 1991, 351:153-155.
2. Braconi C., Kogure T., Valeri N., Huang N., Nuovo G., Costinean S., Negrini M., Miotto E., Croce C.M., Patel T. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011, 30:4750-4756.
3. Brown C.J., Ballabio A., Rupert J.L., Lafreniere R.G., Grompe M., Tonlorenzi R., Willard H.F. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 1991, 349:38-44.
4. Cohen Y., Xing M., Mambo E., Guo Z., Wu G., Trink B., Beller U., Westra W.H., Ladenson P.W., Sidransky D. BRAF mutation in papillary thyroid carcinoma. J. Natl. Cancer Inst. 2003, 95:625-627.
5. Dinger M.E., Amaral P.P., Mercer T.R., Pang K.C., Bruce S.J., Gardiner B.B., Askarian-Amiri M.E., Ru K., Solda G., Simons C., Sunkin S.M., Crowe M.L., Grimmond S.M., Perkins A.C., Mattick J.S. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res. 2008, 18:1433-1445.
6. Eades G., Zhang Y.S., Li Q.L., Xia J.X., Yao Y., Zhou Q. Long non-coding RNAs in stem cells and cancer. World J. Clin. Oncol. 2014, 5:134-141.
7. Eddy S.R. Non-coding RNA genes and the modern RNA world. Nat. Rev. Genet. 2001, 2:919-929.
8. Ge X., Chen Y., Liao X., Liu D., Li F., Ruan H., Jia W. Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer. Med. Oncol. 2013, 30:588.
9. Gibb E.A., Brown C.J., Lam W.L. The functional role of long non-coding RNA in human carcinomas. Mol. Cancer 2011, 10:38.
10. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M., Hung T., Argani P., Rinn J.L., Wang Y., Brzoska P., Kong B., Li R., West R.B., van de Vijver M.J., Sukumar S., Chang H.Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
11. Han L., Zhang K., Shi Z., Zhang J., Zhu J., Zhu S., Zhang A., Jia Z., Wang G., Yu S., Pu P., Dong L., Kang C. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int. J. Oncol. 2012, 40:2004-2012.
12. He H., Nagy R., Liyanarachchi S., Jiao H., Li W., Suster S., Kere J., de la Chapelle A. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res. 2009, 69:625-631.
13. He H., Li W., Liyanarachchi S., Jendrzejewski J., Srinivas M., Davuluri R.V., Nagy R., de la Chapelle A. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2. J. Clin. Endocrinol. Metab. 2015, 100:E164-E172.
14. Huang Y., Prasad M., Lemon W.J., Hampel H., Wright F.A., Kornacker K., LiVolsi V., Frankel W., Kloos R.T., Eng C., Pellegata N.S., de la Chapelle A. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:15044-15049.
15. Huang D.W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37:1-13.
16. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
17. Hung T., Chang H.Y. Long noncoding RNA in genome regulation. RNA Biol. 2014, 7:582-585.
18. Jendrzejewski J., He H., Radomska H.S., Li W., Tomsic J., Liyanarachchi S., Davuluri R.V., Nagy R., de la Chapelle A. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc. Natl. Acad. Sci. 2012, 109:8646-8651.
19. Khosla S., Aitchison A., Gregory R., Allen N.D., Feil R. Parental allele-specific chromatin configuration in a boundary-imprinting-control element upstream of the mouse H19 gene. Mol. Cell. Biol. 1999, 19:2556-2566.
20. Lee J.T. Epigenetic regulation by long noncoding RNAs. Science 2012, 338:1435-1439.
21. Lee M.P., DeBaun M.R., Mitsuya K., Galonek H.L., Brandenburg S., Oshimura M., Feinberg A.P. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:5203-5208.
22. Li X. A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells. Exp. Ther. Med. 2013, 5:1143-1146.
23. Li X., Abdel-Mageed A.B., Kandil E. BRAF mutation in papillary thyroid carcinoma. Int. J. Clin. Exp. Med. 2012, 5:310-315.
24. Li X., Abdel-Mageed A.B., Mondal D., Kandil E. The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers. Thyroid 2013, 23:209-218.
25. Liu J.H., Chen G., Dang Y.W., Li C.J., Luo D.Z. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. Asian Pac. J. Cancer Prev. 2014, 15:2971-2977.
26. Mattick J.S. Non-coding RNA. Hum. Mol. Genet. 2006, 15:R17-R29.
27. Melillo R.M., Castellone M.D., Guarino V., De Falco V., Cirafici A.M., Salvatore G., Caiazzo F., Basolo F., Giannini R., Kruhoffer M., Orntoft T., Fusco A., Santoro M. The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J. Clin. Invest. 2005, 115:1068-1081.
28. Moran V.A., Perera R.J., Khalil A.M. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012, 40:6391-6400.
29. Omur O., Baran Y. An update on molecular biology of thyroid cancers. Crit. Rev. Oncol. Hematol. 2014, 90:233-252.
30. Ponjavic J., Oliver P.L., Lunter G., Ponting C.P. Genomic and transcriptional co-localization of protein-coding and long non-coding RNA pairs in the developing brain. PLoS Genet. 2009, 5:e1000617.
31. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136:629-641.
32. Prensner J.R., Chinnaiyan A.M. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011, 1:391-407.
33. Qiao H.P., Gao W.S., Huo J.X., Yang Z.S. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac. J. Cancer Prev. 2013, 14:1077-1082.
34. Raman P., Koenig R.J. Pax-8-PPAR-γ fusion protein in thyroid carcinoma. Nat. Rev. Endocrinol. 2014, 10:616-623.
35. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E., Chang H.Y. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
36. Roberts T.C., Morris K.V., Weinberg M.S. Perspectives on the mechanism of transcriptional regulation by long non-coding RNAs. Epigenetics 2014, 9:13-20.
37. Rosenbaum M.A., McHenry C.R. Contemporary management of papillary carcinoma of the thyroid gland. Expert. Rev. Anticancer. Ther. 2009, 9:317-329.
38. Schlitt T., Palin K., Rung J., Dietmann S., Lappe M., Ukkonen E., Brazma A. From gene networks to gene function. Genome Res. 2003, 13:2568-2576.
39. Sun W., Wu Y., Yu X., Liu Y., Song H., Xia T., Xiao B., Guo J. Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance. Tumour Biol. 2013, 34:2697-2701.
40. Sun M., Jin F.Y., Xia R., Kong R., Li J.H., Xu T.P., Liu Y.W., Zhang E.B., Liu X.H., De W. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer 2014, 14:319.
41. Tafer H., Hofacker I.L. RNAplex: a fast tool for RNA-RNA interaction search. Bioinformatics 2008, 24:2657-2663.
42. Wang L., Fu D., Qiu Y., Xing X., Xu F., Han C., Xu X., Wei Z., Zhang Z., Ge J., Cheng W., Xie H.L. Genome-wide screening and identification of long noncoding RNAs and their interaction with protein coding RNAs in bladder urothelial cell carcinoma. Cancer Lett. 2014, 349:77-86.
43. Wang Y., Guo Q., Zhao Y., Chen J., Wang S., Hu J., Sun Y. BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma. Oncol. Lett. 2014, 8:1947-1952.
44. Yoon H., He H., Nagy R., Davuluri R., Suster S., Schoenberg D., Pellegata N., Chapelle A.L. Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest. Int. J. Cancer 2007, 121:767-775.